Seng-lai Thomas
Senior Director
Microbiology
Biotech Umea
Sweden
Biography
Seng-Lai Tan is a Senior Director and the Head of Immunology Research at FORMA Therapeutics. He is interested in advancing mechanistic understanding and preclinical proof of confidence for novel therapeutic agents in oncology and autoimmune disease. Prior to joining FORMA, Dr. Tan led cross-functional and therapeutics teams in both large and small molecule drug discovery and development programs at Eli Lilly, Amgen, Roche and EMD Serono.
Research Interest
Microbiology
